18 results
8-K
EX-1.1
ARCT
Arcturus Therapeutics Holdings Inc
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
, contamination, release or other activity involving any kind of hazardous, toxic or other wastes, pollutants, contaminants, petroleum products or other … hazardous or toxic substances, chemicals or materials (“Hazardous Substances”) by, due to, on behalf of, or caused by the Company or any Subsidiary
8-K
EX-1.1
ARCT
Arcturus Therapeutics Holdings Inc
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
, discharge, emission, contamination, release or other activity involving any kind of hazardous, toxic or other wastes, pollutants, contaminants … , petroleum products or other hazardous or toxic substances, chemicals or materials (“Hazardous Substances”) by, due to, on behalf of, or caused by the Company
8-K
EX-10.1
8xgpp
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-1.1
50cycxii5 g0zful5c6
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-10.1
co8o0k
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
vxtg0yiojgohxw
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.1
i8p i6wzz2cm5q
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
325ff4k13x anp45r71j
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
10-K
yckrujzoi63
16 Mar 20
Annual report
11:09am
S-4
nj2mzuu hoctvq6q73v
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
424B3
ejddiqwx
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
l0ymcx3pond 7hz7ie
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
- Prev
- 1
- Next